ID   ME1042
AC   CVCL_A1SG
SY   ME 1042
DR   cancercelllines; CVCL_A1SG
DR   Wikidata; Q105510106
RX   PubMed=22383533;
RX   PubMed=23455323;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533; PubMed=23455323).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
RX   PubMed=22383533; DOI=10.1158/1535-7163.MCT-11-0676;
RA   Dutton-Regester K., Irwin D., Hunt P., Aoude L.G., Tembe V.,
RA   Pupo G.M., Lanagan C., Carter C.D., O'Connor L., O'Rourke M.,
RA   Scolyer R.A., Mann G.J., Schmidt C.W., Herington A., Hayward N.K.;
RT   "A high-throughput panel for identifying clinically relevant mutation
RT   profiles in melanoma.";
RL   Mol. Cancer Ther. 11:888-897(2012).
//
RX   PubMed=23455323; DOI=10.1038/onc.2013.45;
RA   Becker T.M., Boyd S.C., Mijatov B., Gowrishankar K., Snoyman S.,
RA   Pupo G.M., Scolyer R.A., Mann G.J., Kefford R.F., Zhang X.-D.,
RA   Rizos H.;
RT   "Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3
RT   transcription factor.";
RL   Oncogene 33:1158-1166(2014).
//